Fortune and Great Place to Work® Name Amgen One of the World's Best Workplaces™ in 2021

Amgen Ranks #8 Among Top 25 Companies

THOUSAND OAKS, Calif., Oct. 26, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has been selected as one of the World's Best Workplaces™ for 2021 by Fortune magazine and Great Place to Work®Amgen ranked eighth among the 25 companies named to the list.  Those on the list were selected from 10,000 companies, representing the voices of nearly 20 million employees in more than 100 countries.

"We are very proud of this honor," said Robert A. Bradway, Amgen's chairman and chief executive officer. "To be recognized on a global scale demonstrates our ongoing commitment to providing staff with an environment in which they are able to grow and thrive — even during challenging times."

"The World's Best Workplaces are the most sweeping and consistent examples of inclusive company cultures we've ever known," said Michael C. Bush, chief executive officer of Great Place to Work.  "In a global workforce, alignment is everything, and these companies are fortifying their culture around the world — a nearly impossible feat. Even when tested by the pandemic, these companies recognize sub-communities in each region and their leaders carry an equitable employee experience across cultures."

Earlier this year, Amgen was ranked by Great Place to Work as the seventh best workplace in Europe. Additionally, 25 Amgen affiliates around the world have either been certified or recognized by Great Place to Work nationally.  The Fortune World's Best Workplaces list is available at

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit and follow us on  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)


Cision View original content to download multimedia: